Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Alprostadil-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil adverse reaction |
Causative agent (attribute) |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to alprostadil (finding) |
Causative agent (attribute) |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
alprostadil 500 microgrammes/mL, ampoule de 1 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 20micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 10micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 5micrograms injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 10micrograms injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 20micrograms injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
alprostadil 10micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
alprostadil 20micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 10micrograms injection cartridge continuation pack (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 20micrograms injection cartridge continuation pack (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 125micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 250micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 500micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 1000micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 40micrograms injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
alprostadil 40micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 40micrograms injection cartridge continuation pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
alprostadil 20micrograms cartridge syringe injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 10micrograms cartridge syringe injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 5mcg/mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 20.2mcg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 40.0mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 10.16mcg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 125mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 250mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 500mcg pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 1000mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil + alprostadil alfadex + lactose, anhydrous 12.45mcg/402.55mcg/56.3mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 500mcg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing alprostadil in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 20micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 10micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|